Exagen, Inc. (XGN)
8.13
-0.17
(-2.05%)
USD |
NASDAQ |
Sep 30, 16:00
8.13
0.00 (0.00%)
After-Hours: 20:00
Exagen Cash and Short Term Investments (Quarterly) : 24.59M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.59M |
| March 31, 2026 | 21.51M |
| December 31, 2025 | 32.22M |
| September 30, 2025 | 35.65M |
| June 30, 2025 | 30.03M |
| March 31, 2025 | 11.19M |
| December 31, 2024 | 22.04M |
| September 30, 2024 | 22.04M |
| June 30, 2024 | 24.48M |
| March 31, 2024 | 27.27M |
| December 31, 2023 | 36.49M |
| September 30, 2023 | 28.45M |
| June 30, 2023 | 31.47M |
| March 31, 2023 | 52.18M |
| December 31, 2022 | 62.39M |
| September 30, 2022 | 68.70M |
| June 30, 2022 | 76.39M |
| March 31, 2022 | 89.75M |
| December 31, 2021 | 99.44M |
| September 30, 2021 | 106.77M |
| June 30, 2021 | 112.58M |
| March 31, 2021 | 118.05M |
| December 31, 2020 | 57.45M |
| September 30, 2020 | 61.43M |
| June 30, 2020 | 63.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 68.65M |
| December 31, 2019 | 72.08M |
| September 30, 2019 | 77.83M |
| June 30, 2019 | 16.24M |
| March 31, 2019 | 14.33M |
| December 31, 2018 | 13.16M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 2.509M |
| September 30, 2015 | 2.737M |
| June 30, 2015 | 2.917M |
| March 31, 2015 | 3.498M |
| December 31, 2014 | 4.605M |
| September 30, 2014 | 7.123M |
| June 30, 2014 | 6.118M |
| March 31, 2014 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 115.20M |
| BioRestorative Therapies, Inc. | 3.592M |
| CareDx, Inc. | 373.64M |
| Natera, Inc. | 1.092B |
| Sera Prognostics, Inc. | 46.44M |